Editas Medicine Demonstrates First Achievement of In Vivo Editing in Non-human Primate Retinas – GlobeNewswire (press release)
|
Editas Medicine Demonstrates First Achievement of In Vivo Editing in Non-human Primate Retinas
GlobeNewswire (press release) CAMBRIDGE, Mass., May 13, 2017 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced results from a pre-clinical study demonstrating the first achievement of efficient editing of the CEP290 … |
